“President of Telafer University Participates in Research Team Publishing Peer-Reviewed Study in a High-Ranking International Journal”

“President of Telafer University Participates in Research Team Publishing Peer-Reviewed Study in a High-Ranking International Journal”

As part of its ongoing commitment to advance scientific research and enriching the body of academic literature, a research team from the University of Telafer has successfully published a peer-reviewed scientific study in the prestigious German journal Naunyn-Schmiedeberg’s Archives of Pharmacology, which is ranked in the second quartile (Q2) within the Scopus global database and published by Springer.

The research team included Professor Dr. Abdulaziz Ahmed Aziz, President of the University of Telafer; Dr. Iman Mohammed Saeed Jalood, Lecturer and Coordinator of the Basic Sciences Branch at the College of Nursing; Assistant Lecturer Ammar Khalo, Director of the Department of Studies and Planning; and Assistant Lecturer Faheema Ismail—representing a distinguished model of collaborative academic research.

The study focused on exploring the complex relationship between diabetes and cancer, two major global health challenges. The researchers identified shared biological mechanisms that link the two diseases, including hyperinsulinemia, chronic inflammation, and oxidative stress, all of which contribute to creating a microenvironment conducive to the development of certain types of malignancies.

The study also examined the unique clinical challenges faced by patients suffering from both conditions, emphasizing the role of biomarkers in tumor classification, prognosis prediction, and guiding therapeutic decisions. Additionally, it provided a comprehensive analysis of the molecular profiles associated with pancreatic, colorectal, breast, liver, and lung cancers.

This scientific publication marks a significant contribution to the University of Telafer’s research portfolio and represents a valuable addition to global scientific knowledge. It paves the way for innovative therapeutic strategies based on a deeper understanding of biomarker signatures, ultimately enhancing the quality of healthcare for patients burdened with both diabetes and cancer. The study contributes meaningfully to the advancement of personalized and precision medicine in this complex domain.